17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer

This study is ongoing, but not recruiting participants.

Study NCT00096109 Information provided by National Cancer Institute (NCI)

First Received: November 9, 2004 Last Updated: April 14, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	January 2008 (Final data collection date for primary outcome measure)